Form 8-K - Current report:
SEC Accession No. 0001193125-23-256912
Filing Date
2023-10-16
Accepted
2023-10-16 16:28:33
Documents
17
Period of Report
2023-10-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d533486d8k.htm   iXBRL 8-K 32922
2 EX-99.1 d533486dex991.htm EX-99.1 13445
7 GRAPHIC g533486dsp01.jpg GRAPHIC 6388
8 GRAPHIC g533486page002.jpg GRAPHIC 3405
9 GRAPHIC g533486page1a.jpg GRAPHIC 6034
  Complete submission text file 0001193125-23-256912.txt   247665

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20231016.xsd EX-101.SCH 3101
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20231016_def.xml EX-101.DEF 16294
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20231016_lab.xml EX-101.LAB 26751
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20231016_pre.xml EX-101.PRE 17032
11 EXTRACTED XBRL INSTANCE DOCUMENT d533486d8k_htm.xml XML 5776
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 231327605
SIC: 2836 Biological Products, (No Diagnostic Substances)